Vitality Watch

Dossier clinicaltrials trial late 08-sep-2026
Large or late-phase randomized human trial

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

Key claim: A clinical trial will compare family-augmented HELP (FAM-HELP) with standard HELP on delirium incidence and severity plus patient- and family-reported outcomes in hospitalized older adults.

Abstract

The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following:

  1. To compare the effectiveness of FAM-HELP and HELP in reducing both the incidence of delirium and its severity.
  2. To compare the effectiveness of FAM-HELP and HELP in improving patient- and family-reported outcomes.
  3. To explore the implementation context, process, and outcomes of the FAM-HELP program in diverse hospital settings.

Why this matters

Delirium in hospitalized elders is a major driver of downstream cognitive decline and mortality, and HELP is one of the few non-pharmacologic programs with established effect. Testing whether formalizing family caregiver involvement augments that effect would extend social-connection evidence from epidemiologic association into a hard clinical endpoint in a controlled setting.

Source

Link

Briefing card

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Stage: trial late · clinicaltrials · 08-sep-2026

A clinical trial will compare family-augmented HELP (FAM-HELP) with standard HELP on delirium incidence and severity plus patient- and family-reported outcomes in hospitalized older adults.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT05929703

build build 880 · 2bcef25 · 2026-11-18